Methicillin resistant bacterial infections give a tough
challenge in the selection of antibiotics. Traditional use
of antibiotics is worsening the problem day by day. So, it
is essential to sort out other strategies which can replace
antibiotic therapy successfully. Bacteriocins are the
proteinaceous compounds with a narrower spectrum of
antimicrobial activity but its use as antibiotic is not
common. No one has ever tried to use it for the treatment of
infections. Presently, we have isolated bacteriocin
producing bacteria effective against methicillin resistant
bacteria. It will help in controlling MRSA infections as
well as provide a new strategy to treat reemerging
infections.